Efficacy and Tolerability of Belatacept in Heart Transplant Recipients

被引：0
|
作者：
Loethen, A. [1 ]
Lavelle, R. [2 ]
Sarswat, N. [2 ]
Chung, B. [3 ]
Smith, B. [4 ]
Kalantari, S. [5 ]
Grinstein, J. [6 ]
Nguyen, A. [7 ]
Belkin, M. [8 ]
Murks, C. [8 ]
Riley, T. [9 ]
Powers, J. [7 ]
Jones, A. [10 ]
Kim, G. [8 ]
Pinney, S. [8 ]
机构：
[1] Univ Chicago Med, Pharm, Chicago, IL USA
[2] Univ Chicago Hosp, Glencoe, IL USA
[3] Univ Chicago, Chicago, IL USA
[4] Univ Chicago, Med Ctr, Chicago, IL USA
[5] Univ Chicago, Chicago, IL USA
[6] MedStar Heart & Vasc Inst, Chicago, IL USA
[7] Univ Chicago Med, Chicago, IL USA
[8] Univ Chicago, Chicago, IL USA
[9] Univ Chicago, Med Ctr, Matteson, IL USA
[10] Univ Chicago Med, Willow Springs, IL USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2023年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
163
引用
收藏
页码：S81 / S82
页数：2
相关论文
共 50 条
  • [41] Bridging Therapy With Belatacept in High MELD Liver Transplant Recipients
    Sparkes, T.
    Masters, B.
    Hanish, S.
    Potosky, D.
    Hutson, W.
    LaMattina, J.
    Barth, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [42] Incidence of Opportunistic Infections in Elderly Kidney Transplant Recipients on Belatacept
    Khalil, K.
    Jonchhe, S.
    Stern, J.
    Robalino, R.
    Stewart, Z. A.
    Mehta, S. A.
    Ali, N.
    Neumann, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 779 - 779
  • [43] Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Adult Kidney Transplant Recipients
    Shen, Jinshan
    Townsend, Robert
    You, Xiaoli
    Shen, Yun
    Zhan, Ping
    Zhou, Zexun
    Geng, Dong
    Wu, Dianna
    McGirr, Nadia
    Soucek, Kathleen
    Proszynski, Elizabeth
    Pursley, Janice
    Masson, Eric
    CLINICAL DRUG INVESTIGATION, 2014, 34 (02) : 117 - 126
  • [44] Belatacept conversion in adolescent and young adult kidney transplant recipients
    Gupta, Charu
    Petyak, Christy
    Sgambat, Kristen
    Moudgil, Asha
    CLINICAL TRANSPLANTATION, 2023, 37 (03)
  • [45] Conversion to a Belatacept Based Immunosuppression Regimen in Renal Transplant Recipients
    Paplaczyk, K.
    Cunningham, K.
    D'Agostino, C.
    Pinelli, D.
    Schulte, J.
    Shetty, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 439 - 440
  • [46] Belatacept reduces skin cancer risk in kidney transplant recipients
    Wang, Mike
    Mittal, Amit
    Colegio, Oscar R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (04) : 996 - 998
  • [47] An Integrated Safety Profile Analysis of Belatacept in Kidney Transplant Recipients
    Grinyo, Josep
    Charpentier, Bernard
    Pestana, Jose Medina
    Vanrenterghem, Yves
    Vincenti, Flavio
    Reyes-Acevedo, Rafael
    Apanovitch, Anne Marie
    Gujrathi, Sheila
    Agarwal, Mamta
    Thomas, Dolca
    Larsen, Christian P.
    TRANSPLANTATION, 2010, 90 (12) : 1521 - 1527
  • [48] Time-Limited Therapy with Belatacept in Kidney Transplant Recipients
    Letellier, Thibault
    Kervella, Delphine
    Sadek, Abderrahmane
    Masset, Christophe
    Garandeau, Claire
    Fourgeux, Cynthia
    Gourain, Victor
    Poschmann, Jeremie
    Blancho, Gilles
    Ville, Simon
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [49] Belatacept Based Immunosuppression and Incidence of Proteinuria in Kidney Transplant Recipients
    Villicana, R.
    Peng, A.
    Kahwaji, J.
    Choi, J.
    Vo, A.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [50] Early Conversion to Belatacept in High Risk Renal Transplant Recipients
    Santeusanio, A.
    Bhansali, A.
    Shapiro, R.
    Delaney, V.
    Florman, S.
    De Boccardo, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 686 - 686
12345